Detalhe da pesquisa
1.
Host genetic variability and determinants of severe COVID-19.
Trends Genet
; 39(3): 169-171, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379742
2.
Molecular and nutritional markers in head and neck cancer.
Curr Opin Oncol
; 36(3): 123-127, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441194
3.
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Eur J Nucl Med Mol Imaging
; 50(9): 2727-2735, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086272
4.
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 49(11): 3878-3891, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562529
5.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Invest New Drugs
; 39(6): 1641-1648, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322775
6.
Correlations between long-term quality of life and patient needs and concerns following head and neck cancer treatment and the impact of psychological distress. A multicentric cross-sectional study.
Eur Arch Otorhinolaryngol
; 278(7): 2437-2445, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901366
7.
Optimizing drug development in oncology by clinical trial simulation: Why and how?
Brief Bioinform
; 19(6): 1203-1217, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575140
8.
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
Invest New Drugs
; 38(1): 160-171, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402427
9.
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.
Breast Cancer Res Treat
; 176(1): 149-157, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30949798
10.
Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Eur J Nucl Med Mol Imaging
; 46(7): 1581, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30980100
11.
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Eur J Nucl Med Mol Imaging
; 46(3): 558-568, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30612162
12.
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
BMC Cancer
; 19(1): 305, 2019 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943943
13.
Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.
Nucleic Acids Res
; 45(7): 4131-4141, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27994032
14.
Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric study.
Eur Arch Otorhinolaryngol
; 276(9): 2531-2539, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240456
15.
Quality of Randomized Controlled Trials Reporting in the Treatment of Adult Patients with High-Grade Gliomas.
Oncologist
; 23(3): 337-345, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133516
16.
"As du Coeur" study: a randomized controlled trial on physical activity maintenance in cardiovascular patients.
BMC Cardiovasc Disord
; 18(1): 77, 2018 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720097
17.
"As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.
BMC Cardiovasc Disord
; 18(1): 225, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522438
18.
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.
Br J Cancer
; 117(7): 947-953, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28850564
19.
Multicenter prospective micro-costing study evaluating mandibular free-flap reconstruction.
Eur Arch Otorhinolaryngol
; 274(2): 1103-1111, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796554
20.
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
Invest New Drugs
; 39(1): 287-292, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500464